Track the Apotea stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Apotea has published 1 reports. Market capitalisation: €7.9bn. The latest transaction was reported on 4 February 2026 (Purchase). Among the most active insiders: Cecilia Qvist. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration